March 27, 2024 – Notification on FLOLAN (epoprostenol sodium) 0.5 mg/vial (DIN 02230845) and 1.5 mg/vial (DIN 02230848) with regards to changes on the use conditions of the reconstituted solution
March 5, 2018 - Important safety information (PDF - 221 KB) from GSK on FLOLAN (epoprostenol sodium) used with polyethylene terephlalate (PET) or polyethylene terephthalate glycol (PETG) Administration Sets
July 27, 2016 - Important safety information (PDF - 3.2 MB) from GSK on FLOLAN (epoprostenol sodium): Administration with a reformulated diluent.
April 19, 2013 - Important safety information (PDF - 671 KB) regarding the use of FLOLAN.
Patient information:
April 24, 2013 - Important information (PDF - 658 KB) for patients regarding the use of FLOLAN.
You are leaving our website
The information you are about to be referred to may not comply with the local regulatory requirements. Further information relevant to the local environment is available from the company or via the Product Information.
